Pay in 4 interest-free payments of $10.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
In pancreatic carcinoma (MIA PaCa-2) and melanoma (A375) xenograft model
Formula: C26H26F3N7O2
36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10
LGK974 is a highly potent
R-(+)-ETOMOXIR
TRX-818 - CAS# 1256037-58-7 039 In pancreatic carcinoma (MIA PaCa-2)TRX 818, also known as Foslinanib, CVM 1118, CAS No. 1256037 58 7, is an orally bioavailable agent with potential antineoplastic and anti vasculogenic mimicry (VM) activities. Although the exact multiple mechanisms of action through which this agent exerts its effects have yet to be fully elucidated, TRX 818, upon oral administration appears to induce cancer cell apoptosis and inhibits cancer cell proliferation. This agent also prevents tumor cell VM
US$ 82.00
US$ 79.00
US$ 177.50